Isoform-selective substrates of nitric oxide synthase

Journal of Medicinal Chemistry

Volumn 46, Issue 12, 2003, Pages 2271-2274

  Jia, Qiang ^a   Cai, Tingwei ^a   Huang, Mingchuan ^a   Li, Huiying ^b   Xian, Ming ^a   Poulos, Thomas L ^b   Wang, Peng G ^a  

^a WAYNE STATE UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISOENZYME; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ARTICLE; BINDING AFFINITY; ENZYME MECHANISM; ENZYME SUBSTRATE; REACTION ANALYSIS; SYNTHESIS;

GUANIDINES; HEMOGLOBINS; ISOENZYMES; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE I; NITRIC OXIDE SYNTHASE TYPE II; STRUCTURE-ACTIVITY RELATIONSHIP; SUBSTRATE SPECIFICITY;

EID: 0038440529     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm0340703     Document Type: Article

References (29)

1. Moncada, S.; Palmer, R. M.; Higgs, E. A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 1991, 43, 109-142.
2. Tomasian, D.; Keaney, J. F.; Vita, J. A. Antioxidants and the bioactivity of endothelium-derived nitric oxide. Cardiovasc. Res. 2000, 47, 426-435.
3. Brennan, P. A. The actions and interactions of nitric oxide in solid tumours. Eur. J. Surg. Oncol. 2000, 26, 434-437.
4. Grisham, M. B.; Jourd'Heuil, D.; Wink, D. A. Nitric oxide. I. Physiological chemistry of nitric oxide and its metabolites: implications in inflammation. Am. J. Physiol. 1999, 276, G315-G321.
5. Christopherson, K. S.; Bredt, D. S. Nitric oxide in excitable tissues: physiological roles and disease. J. Clin. Invest. 1997, 100, 2424-2429.
6. Bredt, D. S. Endogenous nitric oxide synthesis: biological functions and pathophysiology. Free Radical Res. 1999, 31, 577- 596.
7. Alderton, W. K.; Cooper, C. E.; Knowles, R. G. Nitric oxide synthases: structure, function and inhibition. Biochem. J. 2001, 357, 593-615.
8. Roman, L. J.; Martasek, P.; Masters, B. S. Intrinsic and extrinsic modulation of nitric oxide synthase activity. Chem. Rev. 2002, 102, 1179-1190.
9. Jia, Q.; Janczuk, A. J.; Cai, T.; Xian, M.; Wen, Z.; et al. NO donors with anticancer activity. Expert Opin. Ther. Pat. 2002, 12, 819-826.
10. Auvin, S.; Auguet, M.; Navet, E.; Harnett, J. J.; Viossat, I.; et al. Novel inhibitors of neuronal nitric oxide synthase with potent antioxidant properties. Bioorg. Med. Chem. Lett. 2003, 13, 209-212.
11. Marletta, M. A. Approaches toward selective inhibition of nitric oxide synthase. J. Med. Chem. 1994, 37, 1899-1907.
12. Dijols, S.; Perollier, C.; Lefevre-Groboillot, D.; Pethe, S.; Attias, R.; et al. Oxidation of N(ω)-hydroxyarginine analogues by NO-synthase: the simple, non amino acid N-butyl N′ -hydroxyguanidine is almost as efficient an NO precursor as N(ω)-hydroxyarginine. J. Med. Chem. 2001, 44, 3199-3202.
13. Xian, M.; Fujiwara, N.; Wen, Z.; Cai, T.; Kazuma, S.; et al. Novel substrates for nitric oxide synthases. Bioorg. Med. Chem. 2002, 10, 3049-3055.
14. Mansuy, D.; Boucher, J. L. Oxidation of N-hydroxyguanidines by cytochromes P450 and NO-synthases and formation of nitric oxide. Drug Metab. Rev. 2002, 34, 593-606.
15. Li, H.; Shimizu, H.; Flinspach, M.; Jamal, J.; Yang, W.; et al. The novel binding mode of N-alkyl-N′-hydroxyguanidine to neuronal nitric oxide synthase provides mechanistic insights into NO biosynthesis. Biochemistry 2002, 41, 13868-13875.
16. Roberts, J. D.; Mazur, R. H. Small-ring compounds. IV. Interconversion reactions of cyclobutyl, cyclopropylcarbinyl, and allylcarbinyl derivatives. J. Am. Chem. Soc. 1951, 73, 2509-2520.
17. Kai, Y.; Knochel, P.; Kwiatkowski, S.; Dunitz, J. D.; Oth, J. F. M.; et al. Structure, synthesis, and properties of some persubstituted 1,2-dinitroethanes. In quest of nitrocyclopropyl-anion derivatives. Helv. Chim. Acta 1982, 65, 137-161.
18. Dijols, S.; Boucher, J. L.; Lepoivre, M.; Lefevre-Groboillot, D.; Moreau, M.; et al. First non-α-amino acid guanidines acting as efficient NO precursors upon oxidation by NO-synthase II or activated mouse macrophages. Biochemistry 2002, 41, 9286-9292.
19. Huang, H.; Hah, J. M.; Silverman, R. B. Mechanism of nitric oxide synthase. Evidence that direct hydrogen atom abstraction from the O-H bond of NG-hydroxyarginine is not relevant to the mechanism. J. Am. Chem. Soc. 2001, 123, 2674-2676.
20. Moynihan, H. A.; Roberts, S. M.; Weldon, H.; Allcock, G. H.; Anggard, E. E.; et al. Synthesis and biological activity of the novel nitric oxide synthase inhibitor Nw-hydroxy-Nw-methylL-arginine. J. Chem. Soc., Perkin Trans. 1 1994, 769-771.
21. Moali, C.; Boucher, J. L.; Sari, M. A.; Stuehr, D. J.; Mansuy, D. Substrate specificity of NO synthases: detailed comparison of L-arginine, homo-L-arginine, their N ω-hydroxy derivatives, and N ω-hydroxynor-L-arginine. Biochemistry 1998, 37, 10453-10460.
22. Marletta, M. A. Nitric oxide synthase structure and mechanism. J. Biol. Chem. 1993, 268, 12231-12234.
23. Korth, H. G.; Sustmann, R.; Thater, C.; Butler, A. R.; Ingold, K. U. On the mechanism of the nitric oxide synthase-catalyzed conversion of N omega-hydroxyl-L-arginine to citrulline and nitric oxide. J. Biol. Chem. 1994, 269, 17776-17779.
24. Crane, B. R.; Arvai, A. S.; Ghosh, S.; Getzoff, E. D.; Stuehr, D. J.; et al. Structures of the N(ω)-hydroxy-L-arginine complex of inducible nitric oxide synthase oxygenase dimer with active and inactive pterins. Biochemistry 2000, 39, 4608-4621.
25. Tierney, D. L.; Huang, H.; Martasek, P.; Masters, B. S.; Silverman, R. B.; et al. ENDOR spectroscopic evidence for the position and structure of NG-hydroxy-L-arginine bound to holo-neuronal nitric oxide synthase. Biochemistry 1999, 38, 3704-3710.
26. Tierney, D. L.; Huang, H.; Martasek, P.; Roman, L. J.; Silverman, R. B.; et al. ENDOR Spectroscopic Evidence for the Geometry of Binding of Retro-Inverso-Nω-Nitroarginine-Containing Dipeptide Amides to Neuronal Nitric Oxide Synthase. J. Am. Chem. Soc. 2000, 122, 7869-7875.
27. Tantillo, D. J.; Fukuto, J. M.; Hoffman, B. M.; Silverman, R. B.; Houk, K. N. Theoretical Studies on NG-Hydroxy-L-arginine and Derived Radicals: Implications for the Mechanism of Nitric Oxide Synthase. J. Am. Chem. Soc. 2000, 122, 536-537.
28. Raman, C. S.; Li, H.; Martasek, P.; Babu, B. R.; Griffith, O. W.; et al. Implications for isoform-selective inhibitor design derived from the binding mode of bulky isothioureas to the heme domain of endothelial nitric-oxide synthase. J. Biol. Chem. 2001, 276, 26486-26491.
29. Wang, P. G.; Xian, M.; Tang, X.; Wu, X.; Wen, Z.; et al. Nitric oxide donors: chemical activities and biological applications. Chem. Rev. 2002, 102, 1091-1134.